The 2 most recent market catalysts affecting $SANA, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 5, 2026
Corporate Catalyst
Bearish
Impact 75
Sana Biotechnology Reports Third Quarter 2026 Financial Results and Business Updates
Sana Biotechnology reported an adjusted loss of $0.14 per share for Q3 2026, which was better than the FactSet consensus estimate of a $0.15 loss. This earnings beat, while small, …
Jul 13, 2026
Corporate Catalyst
Neutral
Impact 75
Sana Biotechnolog Publishes Peer-Reviewed Letter To Editor In New England Journal Of Medicine
Sana Biotechnology (SANA) has published peer-reviewed long-term data in the New England Journal of Medicine, confirming the safety and efficacy of its HIP-modified islets for Type …
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.